US Merger & Acquisition SEC Filings — April 30, 2026

30-04-2026

On April 30, 2026, New Royal HoldCo I Inc. (successor to Golden Entertainment, Inc.) consummated the Master Transaction Agreement by selling 100% of New OpCo equity to Argento, LLC, distributing a $2.75 per share dividend to shareholders, and merging into a VICI Properties Inc. subsidiary, with each New HoldCo share converting to 0.902 VICI shares. The First Lien Credit Agreement was fully terminated and obligations satisfied. Trading on Nasdaq was suspended, delisting via Form 25 initiated, and all directors and certain officers resigned or ceased roles, with the company planning to file Form 15 to terminate SEC reporting obligations.

• ·Equity awards (Company Options, RSUs, PSUs, Restricted Stock) accelerated and vested at target performance, settled net of taxes prior to F-Reorganization.
• ·Nasdaq notified of transaction completion; requested trading suspension, Form 25 for delisting, and plans to file Form 15 for termination of registration under Sections 12(g), 13, and 15(d).
• ·Blake L. Sartini employment terminated post-Merger, receiving severance under employment agreement.

30-04-2026

SM Energy Company closed the sale of certain South Texas assets for a cash purchase price of $950 million, generating net cash proceeds of approximately $900 million after adjustments and costs, advancing momentum toward its $1.0 billion-plus divestiture target. Concurrently, the company announced full redemption of its $819 million aggregate principal amount of 2026 Senior Notes ($419 million 6.75% due September 15, 2026, and $400 million 5.0% due October 15, 2026). The credit facility's borrowing base and lender commitments were reaffirmed at $5.0 billion and $2.5 billion, respectively, supporting balance sheet strengthening.

• ·6.75% Senior Notes redemption planned for June 1, 2026
• ·5.0% Senior Notes redemption planned for May 11, 2026
• ·Merger with Civitas closed on January 30, 2026
• ·Semi-annual borrowing base redetermination completed subsequent to March 31, 2026
• ·Final purchase price for South Texas Divestiture subject to customary post-closing adjustments

30-04-2026

Spire Inc. completed the sale of its gas marketing business, Spire Marketing Inc., to Boardwalk Pipelines, LP for $215 million in cash, effective April 30, 2026. Employees and clients will transition to Boardwalk Continuum Marketing, LLC, sharpening Spire's focus on regulated natural gas utility operations while improving its risk profile and long-term earnings visibility. Proceeds will partially fund the acquisition of the Piedmont Natural Gas Tennessee business and support general corporate purposes.

• ·Stinson LLP served as legal counsel to Spire in the transaction.
• ·Spire operates gas utilities in Alabama, Mississippi, Missouri, and Tennessee.

30-04-2026

SOBR Safe, Inc. (Nasdaq: SOBR) has entered a definitive agreement for a proposed business combination with Clean World Ventures, Inc. (CWV), a zero-carbon green energy technology manufacturer focused on AI data centers and heavy industries, where CWV will own approximately 98% of the combined public company post-closing. The deal, expected in Q3 2026 subject to due diligence, approvals, and $5.5 million pre-close financing ($2.0 million for SOBRsafe's operations), allows independent operation of businesses initially. However, SOBRsafe will explore strategic alternatives to monetize its core alcohol monitoring technology, signaling a major pivot and significant dilution for existing shareholders.

• ·Transaction closing subject to customary due diligence, final binding documents, regulatory and shareholder approvals.
• ·Post-closing board and executive officers to be determined and designated by CWV.
• ·CWV in active discussions with hyperscale data center operators for on-site clean energy solutions.

30-04-2026

Perrigo Company plc completed the divestiture of its branded Dermacosmetics business (including ACO, Biodermal, Emolium, and Iwostin) to Karo Healthcare for total consideration of up to €332.6 million, consisting of €305.6 million upfront cash (including €5.6 million in net working capital adjustments) and up to €27.0 million contingent on net sales milestones over three years. Net proceeds of approximately €306 million will primarily reduce debt, streamlining the portfolio and advancing the Three-S plan (Stabilize, Streamline, Strengthen). In 2025, the business generated €120 million in net sales, representing approximately 5% of Perrigo’s adjusted operating income.

• ·Impairment charges of $1,363.1 million in 2025 primarily due to $1.3 billion goodwill impairment and $33.6 million equity method investment in Kazmira LLC.
• ·Other 2025 pre-tax adjustments include $71.9 million restructuring, $59.0 million unusual litigation, $223.5 million amortization, $0.9 million infant formula remediation, and $26.1 million other (including $12.2 million divestiture consulting fees).

30-04-2026

Plutonian Acquisition Corp II, a Cayman Islands blank check company, priced its initial public offering of 10,000,000 units at $10.00 per unit, raising $100 million, with units expected to trade on NYSE under ticker PLUNU starting April 28, 2026, and closing on April 29, 2026. A.G.P./Alliance Global Partners serves as the sole book-running manager, and the company granted a 45-day over-allotment option for up to 1,500,000 additional units. The IPO relates to Form S-1 (File No. 333-293531), declared effective April 27, 2026.

• ·Units consist of one Class A ordinary share and one right to receive 1/4 Class A ordinary share upon initial business combination.
• ·Separate trading expected for shares (PLUN) and rights (PLUNR) after units unbundle.
• ·Registration statement: Form S-1, File No. 333-293531, effective April 27, 2026.

30-04-2026

Bakkt Holdings, Inc. completed its acquisition of Distributed Technologies Research (DTR) on April 30, 2026, by issuing 11,316,775 shares of Class A Common Stock to DTR holders, with potential for up to an additional 725,592 shares related to outstanding warrants. The deal integrates Bakkt’s regulated infrastructure with DTR’s agentic technology and compliance stack to target the $44T global payments market, establishing a 24/7 digital settlement layer using stablecoins. CEO Akshay Naheta emphasized the strategic acceleration of global financial infrastructure re-platforming, though forward-looking statements highlight integration risks and potential failure to realize expected benefits.

• ·Share Purchase Agreement dated January 11, 2026
• ·Bakkt headquartered in Atlanta, GA
• ·Founded in 2018

30-04-2026

SIM Acquisition Corp. I, a blank check company (SPAC), postponed its extraordinary general meeting from May 1, 2026, at 10:00 a.m. to May 7, 2026, at 3:00 p.m. ET to approve the Extension Amendment Proposal, which would extend the initial business combination deadline from July 11, 2026, to July 12, 2027. The shareholder redemption deadline was also extended to May 5, 2026, at 5:00 p.m. ET. No financial performance metrics or period-over-period comparisons were reported.

• ·Proxy Statement filed with SEC on or about April 1, 2026; record date for shareholders: March 25, 2026.
• ·Meeting location: offices of Ellenoff Grossman & Schole LLP, 1345 Avenue of the Americas, 11th Floor, New York, New York 10105.
• ·Company is an emerging growth company; listed on Nasdaq Stock Market LLC.

30-04-2026

Coeptis Therapeutics Holdings, Inc. completed its merger with Z Squared on April 24, 2026, pursuant to a merger agreement dated April 25, 2025, following a spin-out of its biopharmaceutical operations to subsidiaries distributed to shareholders, while retaining GEAR Therapeutics, Inc. as a subsidiary; the company subsequently changed its name to Z Squared Inc. Pro forma consolidated balance sheet as of December 31, 2025 reflects total assets reduced to $2,849,361 (from historical $16,153,921) with cash at $0 (from $5,674,302), driven by the spin-out adjustments. Pro forma net loss for 2025 improved to $(9,121,669) from historical $(12,277,192) due to lower operating expenses, with sales steady at $1,363,045; however, the 2025 pro forma operating loss of $(10,040,719) worsened from 2024 pro forma $(5,079,880), indicating persistent unprofitability post-spin-out.

• ·GEAR Therapeutics, Inc. excluded from Spin Out and remains a subsidiary of Coeptis; Spin Out Sub received 1,000,000 shares of Coeptis Common Stock and an option to acquire GEAR at future fair market value.
• ·Pro forma stockholders' equity - controlling interests: $2,165,098 as of Dec 31, 2025.
• ·Pro forma customer deposit remains at $599,455.
• ·Subscription receivable remains at $(3,686,544).